AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Company to expand HDL Therapy development program.

Vaccine Weekly

| January 07, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Following a regularly scheduled meeting of the board of directors, Lipid Sciences, Inc., (LIPD) announced the company will now expand the development program for its HDL Therapy platform.

This decision comes as a result of the board of directors' review of the company's strategic plan, results of Lipid Sciences' development program, recently published data on the promise of HDL Therapy, and the board's approval of the 2004 operating plan and budget.

The company plans to develop the HDL Therapy platform along a parallel path with its Viral Immunotherapy platform. The HDL Therapy platform is aimed at developing potential treatments for the reversal of atherosclerosis. This technology is based on a patented process that selectively and rapidly removes lipids from lipoproteins, such as HDL, without harming the proteins that carry the lipid particles. This HDL Therapy has the ability to boost HDL efficiency and the potential to reduce the risk of cardiovascular disease.

The Viral Immunotherapy platform is focused on the removal of lipid coatings from viruses and other lipid-containing infectious agents. The company recently announced an important development milestone for this viral platform with the completion of successful studies in a mouse animal model. The company has now initiated a series of nonhuman primate studies to further validate its unique delipidation technology. The ultimate goal of these studies is the ...

Related articles from newspapers, magazines, journals, and more
The New England Journal of Medicine Editorial Highlights Role of HDL Therapy;...
Press release article from: PR Newswire April 8, 2004 700+ words
...cardiovascular disease)." Lipid Sciences' HDL Therapy platform uses a proprietary...reduced. If successful, Lipid Sciences' HDL Therapy may be able to turn...market." To see the Lipid Sciences' HDL Therapy process in action...
Article in The Journal of the American Medical Association Validates HDL...
Press release article from: PR Newswire November 6, 2003 700+ words
...coronary events. Lipid Sciences' HDL therapy has demonstrated its...to heal itself. Lipid Sciences' proprietary HDL therapy may be able to turn...disease. The ability of Lipid Sciences' HDL therapy to boost HDL efficiency...
Latest HDL Therapy Data Reviewed by Lipid Sciences, Inc. Scientific Advisory...
Press release article from: PR Newswire May 3, 2004 700+ words
Lipid Sciences, Inc. today announced...to the Company's HDL Therapy platform was reviewed at a meeting of the Lipid Sciences' Scientific Advisory...achievement is that Lipid Sciences' HDL Therapy has the potential to...
Initiation of HDL Therapy Safety and Efficacy Study Announced by Lipid...
Press release article from: PR Newswire September 23, 2004 700+ words
...safety and efficacy of Lipid Sciences' HDL Therapy in treating cardiovascular...demonstrating the efficacy of Lipid Sciences' HDL Therapy. This animal study...safety and efficacy of Lipid Sciences' HDL Therapy system in a relevant...
Lipid Sciences Addresses Heightened Market Interest Surrounding HDL Therapy.
Press release article from: PR Newswire December 23, 2003 700+ words
...the value of introducing new ways, such as Lipid Sciences' proprietary HDL Therapy Platform, to treat cardiovascular disease. "Lipid Sciences HDL Therapy Platform has the potential to become an important...
Lipid Sciences' HDL Therapy Noted in BusinessWeek Online Article; 'Good News...
Press release article from: PR Newswire July 29, 2003 700+ words
...29 /PRNewswire/ -- Lipid Sciences, Inc. announced today...study indicate that this HDL therapy not only works but is...development for the field of HDL therapy as a whole and of major significance to Lipid Sciences because it validates...
Lipid Sciences to Expand HDL Therapy Development Program; Review of Strategic...
Press release article from: PR Newswire December 11, 2003 700+ words
...December 8, 2003, Lipid Sciences announced today...program for its HDL Therapy platform. This...plan, results of Lipid Sciences' development...the promise of HDL Therapy, and the Board...the best way for Lipid Sciences to capitalize...represented by ...
Breakthrough Developments in Cardiology Validate Role of HDL Therapy; JAMA...
Press release article from: PR Newswire November 17, 2003 700+ words
...cardiovascular disease. Lipid Sciences' HDL therapy is focused on treating...short-term, acute (HDL) therapy. This confirms Lipid Sciences' belief that the...statin) therapies. Lipid Sciences' HDL therapy has potential as a...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA